Early research (Phase 1)Looking for participantsNCT06686524
What this trial is testing
Clinical Study of CD19 Targeted Universal Chimeric Antigen Receptor T Lymphocytes (UCAR-T) for the Treatment of Refractory Juvenile Dermatomyositis (RJDM)
Who this might be right for
Dermatomyositis, JuvenileDermatomyositis
Chongqing Precision Biotech Co., Ltd 18